Neuropsychological aspects of liver disease and its treatment

Neurochemical Research

Volumn 33, Issue 4, 2008, Pages 683-690

  O'Carroll, R E ^a  

^a UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

Cognition; Hepatic encephalopathy; Memory; Psychology; Psychomotor

Indexed keywords

AMMONIA; BENZODIAZEPINE DERIVATIVE; FLUMAZENIL; PLACEBO;

CEREBROSPINAL FLUID; CLINICAL TRIAL; DRUG EFFECT; DRUG TOLERABILITY; HEPATIC ENCEPHALOPATHY; HUMAN; KIDNEY DONOR; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REVIEW;

ANIMALS; COGNITION DISORDERS; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, GABA-A; TREATMENT OUTCOME;

EID: 40349084007     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9522-7     Document Type: Review

References (60)

1. O'Carroll RE (2004) Neuropsychology. In: EC Johnstone et al (eds) Companion to Psychiatric Studies. Churchill Livingston, Edinburgh, pp 132-149
2. Butterworth RF (2003) Hepatic Encephalopathy. Alcohol Res Health 27(3):240-246
3. Jalan R, Hayes PC (1997) Hepatic encephalopathy and ascites. Lancet 350:1309-1315
4. Collie A (2005) Cognition in liver disease. Liver Int 25(1):1-8
5. Amodio P et al (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19(3-4):253-267
6. Parsons-Smith BG et al (2004) The electroencephalograph in liver disease. Lancet x. ii:867-871
7. Gitlin N, Lewis DC, Hinkley L (1986) The diagnosis and prevalence of sub-clinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 3(1):75-82
8. Ferenci P et al (2002) Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35(3):716-721
9. Masterton G, O'Carroll RE (1995) Psychological assessment in liver disease. Baillieres Clin Gastroenterol 9(4):791-809
10. Weissenborn K et al (1998) The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 28(4):646-653
11. Moore JW et al (1989) Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. A control study J Hepatol 9(3):319-325
12. O'Carroll RE et al (1991) Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet 337:1250-1253
13. Ortiz M et al (2006) Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol 44(1):104-110
14. Schomerus H et al (1981) Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effects on fitness to drive. Dig Dis Sci 26:622-630
15. Dunk AA, Moore JW (1989) Cognitive dysfunction in latent portasystemic encephalopathy. In: Crawford JR, Parker DM (eds) Developments in Clinical and Experimental Neuropsychology. Plenum, London, pp 39-46
16. Watanabe A et al (1995) Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 10(3):239-248
17. Wein C et al (2004) Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 39(3):739-745
18. Yen C-T, Liaw Y-F (1990) Somatosensory evoked potentials and number connection test in the detection of sub-clinical hepatic encephalopathy. Hepatogastroenterol 37:332-334
19. Saxena N et al (2002) Electrophysiological and neuropsychological tests for the diagnosis of sub-clinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 22(3):190-197
20. Davies MG, Rowan MJ, Feely J (1991) Psychometrics in assessing hepatic encephalopathy in a brief review. Ir J Psychol Med 8:144-146
21. Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 17(4):221-227
22. Cossar JA, Hayes PC, O'Carroll RE (1997) Benzodiazepine-like substances and hepatic encephalopathy. CNS Drugs 8(2):91-101
23. Basile AS et al (1990) Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy. Proc Natl Acad Sci USA 87:5263-5267
24. Gammal S et al (1990) Hepatic encephalopathy in an improved model of the thioacetamide-treated rat: evidence for mediation by the benzodiazepine receptor. Hepatology 11:371-378
25. Mullen KD, Szauter KM, Kaminsky-Russ K (1990) "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 336:81-83
26. Basile AS et al (1991) Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med 325:473-478
27. Olasmaa M et al (1990) Endogenous benzodiaizepine receptor ligands in human and animal hepatic encephalopathy. J Neurochem 55:2015-2022
28. Hernandez-Avila CA, Shoemaker WJ, Ortega-Soto HA (1998) Plasma concentrations of endogenous benzodiazepine-receptor ligands in patients with hepatic encephalopathy: a comparative study. J Psychiatry Neurosci 23(4):217-222
29. Avallone R et al (1998) Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of patients with liver cirrhosis with and without overt encephalopathy. Gut 42(6):861-867
30. Ferenci P et al (1989) Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Gastroenterology 96:240-243
31. Grimm G et al (1988) Improvement of hepatic encephalopathy treated with flumazenil. Lancet ii:1392-1394
32. Bansky G et al (1989) Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology 97:744-750
33. Pomier-Layrargues G et al (1994) Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial. Hepatology 19:32-37
34. Gyr K et al (1996) Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study. Gut 39:319-324
35. Gooday R et al (1995) Benzodiazepine receptor antagonism improves reaction-hepatic-encephalopathy. Psychopharmacology 119(3):295-298
36. Als-Nielsen B, Gluud LL, Gluud C (2004) Benzodiazepine receptor antagonists for hepatic encephalopathy. Cochrane Database Syst Rev (2):CD002798
37. Bakti G et al (1987) Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolam. Hepatology 7(4):629-638
38. Dasarathy S, Mullen KD (1998) Benzodiazepines in hepatic encephalopathy: sleeping with the enemy. Gut 42(6):764-765
39. Masterton G, O'Carroll RE (1995) Psychological assessment in liver disease, In: Baillieres Clinical Gastroenterology. 791-809
40. Lockwood AH et al (1991) Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 11:331-336
41. Lockwood AH, Weissenborn K, Butterworth RF (1997) An image of the brain in patients with liver disease. Curr Opin Neurol 10(6):525-533
42. Spahr L et al (2000) Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology 119(3):774-781
43. Butterworth RF et al (1995) Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab Brain Dis 10(4):259-267
44. Hayes PC, Simpson KJ, Garden OJ (2002) Liver and biliary tract disease, In: Davidson's Principles and Practice of Medicine. Churchill Livingstone, Edinburgh, pp 831-888
45. Jalan R et al (1995) A prospective evaluation of changes in function tests following transjugular intrahepatic stent-shunt. J Hepatol 23(6):697-705
46. Neuberger J, Lucey MR (1994) Liver Transplantation: Practice and Management. BMJ Publishing Group
47. Bathgate AJ et al (1999) The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J 44(1):9-10
48. Gross CR et al (1999) Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology 29(2):356-364
49. Tarter RE et al (1990) Sub-clinical hepatic encephalopathy. Comparison before and after orthotopic liver transplantation. Transplantation 50:632-637
50. Tarter RE et al (1991) Quality of life before and after orthotopic heaptic transplanation. Arch Intern Med 151:1521-1526
51. Hellgren A et al (1998) Health-related quality of life after liver transplantation. Liver Transpl Surg 4(3):215-221
52. O'Carroll RE et al (2003) Psychological outcome and quality of life following liver transplantation: a prospective, national, single-center study. Liver Transpl 9(7):712-720
53. Wilson BA et al (1989) The development and validation of a test battery for detecting and monitoring everyday memory problems. J Clin Exp Neuropsychol 11:855-870
54. Middleton PF et al (2006) Living donor liver transplantation-adult donor outcomes: a systematic review. Liver Transpl 12(1):24-30
55. Neuberger J, Price D (2003) Role of living liver donation in the United Kingdom. BMJ 327(7416):676-679
56. Fukunishi I et al (2000) Health status survey of adult patients undergoing living-related liver transplantation. Transplant Proc 32(7):2149-2151
57. Hsu HT et al (2006) Impact of liver donation on quality of life and physical and psychological distress. Transplant Proc 38(7):2102-2105
58. Williams RS et al (2003) Adult-to-adult living donor liver transplant: UK experience. Eur J Gastroenterol Hepatol 15(1):7-14
59. Caplan AL (2001) Proceed with caution: live living donation of lobes of liver for transplantation. Liver Transpl 7(6):494-495
60. McGregor L, O'Carroll RE (2006) Living donor liver transplants. Psychologist 19:138-139